RxDoctor Payments Data

Ashma Davidson

Primary Podiatric Medicine · Statesville, NCNPI 1427311497

Payments from drug & device makers

What this record shows

This record is dominated by other: $27,400 of the $32,291 with a category attached, or 84.9%. Convatec Inc. accounts for 85.1% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $28,037, more than ten times the $222 reported in 2019. Among primary podiatric medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,291in general payments, 2019–2025

Across 175 payments — averaging $184.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$27K
  • Amgen$1K
  • GRT US Holding, Inc.$857
  • Smith+Nephew$619
  • Averitas Pharma Inc.$395
  • Paratek Pharmaceuticals, Inc.$371
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,89115%
  • Other$27,40085%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,291 in reported general payments places this provider in the 95th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$235,039
Medicare patients
550
Services billed
7,010

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip138$3,343
Mupirocin252$2,282
Naproxen86$718
Minocycline Hcl53$503
Doxycycline Hyclate19$402
Methylprednisolone23$114

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Statesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →